The Journal of
Clinical Psychiatry

Panic Disorder

Letter to the Editor May 15, 1998

Nefazodone and the Treatment of Panic

MAJ Timothy R. Berigan, MAJ ; CPT Antonio Casas, CPT ; Jeff Harazin

J Clin Psychiatry 1998;59(5):256-257

Article Abstract

Sir: In a recent review of antidepressants used in treating panic disorder, Dr. Jefferson thoroughly reviews the historical data pertaining to tricyclics, monoamine oxidase inhibitors, and serotonin selective reuptake inhibitors (SSRIs). He makes brief mention of other antidepressants such as venlafaxine, bupropion, trazodone, as well as inositol, but no mention of nefazodone.

Download Free PDF

This PDF is free for all visitors!

Save

Cite

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia

Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Vol 86 • 2025 • Number 2

Read the Current Issue

Original Research

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Original Research

Valbenazine in Elderly Adults With Tardive Dyskinesia

Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Original Research

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Brief Report

Psychosocial Correlates of Optimism among US Military Veterans

View current Issue